Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...

Mobile electrocardiography (mECG) devices can go places a standard 12-lead electrocardiography system can't, with fewer technicians in tow, but it doesn't have the same functionality — their most ...

AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...

AliveCor has secured a new 510(k) clearance from the FDA for its handheld, six-lead electrocardiogram device, unlocking the rapid detection of potentially dangerous cardiovascular side effects that ...

Mayo Clinic, AliveCor develop mobile EKG device to monitor patients at risk of sudden cardiac death Researchers from Rochester, Minn.-based Mayo Clinic and AliveCor, a cardiology-focused medical ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the ...

An ECG – electrocardiogram — reading can be a vital piece of data to have on hand. With it, you get a better look into your heart health, which is invaluable. This guide will take you through using ...

This cohort study assessed ECG parameters in transgender men and women before and after use of gender-affirming hormone therapies. Testosterone use in transgender men was associated with shorter ...

Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Many planned randomized trials to test the efficacy of hydroxychloroquine or related drugs for ...

Sociodemographic and clinical characteristics among men with metastatic prostate cancer: An aged-stratified analysis. Background: Cabazitaxel (Cbz) improves overall survival in patients (pts) with ...